Aquatic Toxicology 116–117 (2012) 8–15
Contents lists available at SciVerse ScienceDirect
Aquatic Toxicology
jou rn al h om epa ge: www.elsevier.com/locate/aquatox
Effects of exposure to the -blocker propranolol on the reproductive behavior
and gene expression of the fathead minnow, Pimephales promelas
Varenka Lorenzi
a
, Alvina C. Mehinto
b
, Nancy D. Denslow
b
, Daniel Schlenk
a,∗
a
Department of Environmental Sciences, University of California Riverside, Riverside, CA, USA
b
Center for Environmental and Human Toxicology and Department of Physiological Sciences, University of Florida, Gainesville, FL, USA
a r t i c l e i n f o
Article history:
Received 6 December 2011
Received in revised form 28 February 2012
Accepted 1 March 2012
Keywords:
Pharmaceutical
Reproduction
Behavior
Fish
Microarray
a b s t r a c t
Human pharmaceutical drugs have been found in surface waters worldwide, and represent an increasing
concern since little is known about their possible effects on wildlife. Propranolol is a common beta-
adrenergic receptor antagonist (-blocker) typically prescribed to people suffering from heart disease
and hypertension. Propranolol has been detected in United States wastewater effluents at concentrations
ranging from 0.026 to 1.90 g/l. In mammals, there is evidence that -blockers can cause sexual dysfunc-
tion, and alter serotonergic pathways which may impact reproductive behavior but little is known about
the effects on fish behavior. The present study tested the effects of propranolol on fecundity, on brain
gene expression and on reproductive behavior of the fathead minnow, Pimephales promelas, a fish that
exhibits male parental care. Sexually mature fathead minnows were housed at a ratio of one male and two
females per tank and exposed to nominal concentrations of 0, 0.1, 1, 10 g/l for 21 days. Measured con-
centrations (±SD) of propranolol were 0.003 ± 0.004, 0.05 ± 0.02, 0.88 ± 0.34 and 4.11 ± 1.19 g/l. There
were no statistically significant differences in fecundity, fertilization rate, hatchability and time to hatch.
Propranolol exposure was not associated with a change in nest rubbing behavior, time spent in the nest or
approaching the females. There was a significant difference in the number of visits to the nest with males
receiving low and medium propranolol treatments. The microarray analysis showed that there were
335 genes up-regulated and 400 genes down-regulated in the brain after exposure to the highest dose
of propranolol. Among those genes, myoglobin and calsequestrin transcripts (fold change = 10.84 and
5.49, respectively) were highly up-regulated. Ontological analyses indicated changes in genes involved
in calcium ion transport, transcription, proteolysis and apoptosis/anti-apoptosis. Pathway analysis indi-
cated that the reduced expression of caspases may lead to impaired neurite outgrowth, neurotransmitter
secretion and brain function in developing organisms. The results showed that exposure to propranolol
at concentrations as high as 4.11 g/l did not significantly impact reproductive behavior or spawning
abilities of fathead minnow but did alter the regulation of genes within the brain of fish.
© 2012 Elsevier B.V. All rights reserved.
1. Introduction
Beta blockers (-blockers) are a class of drugs used to treat
cardiac arrhythmias and hypertension. They act as antagonists of
the beta adrenergic receptors inhibiting the normal epinephrine-
mediated sympathetic actions that would cause an increase in
cardiac output. Propranolol is a non-specific
1
,
2
-blocker and it is
very commonly prescribed worldwide. It was identified in munic-
ipal wastewater effluents at a maximum concentration of 1.9 g/l
in the United States (Huggett et al., 2003), and up to 590 ng/l in
European countries (Ternes, 1998; Andreozzi et al., 2003).
∗
Corresponding author at: 2258 Geology Building, 900 University Ave, Depart-
ment of Environmental Sciences, University of California Riverside, Riverside, CA
92521, USA. Tel.: +1 951 827 7065; fax: +1 951 827 3993.
E-mail address: Daniel.schlenk@ucr.edu (D. Schlenk).
Beta-blockers taken as antihypertensive medication have been
reported to be associated with sexual dysfunction in men (Burnett
and Chanine, 1979; Fogari and Zoppi, 2002). Treatment of healthy
men with propranolol was associated with a significant decrease
in testosterone levels (Rosen et al., 1988). Similar effects were
found in rodent studies, where propranolol inhibited sexual behav-
ior in male rats (Smith et al., 1990). Propranolol can also bind
to serotonin (5-HT) receptors in the brain, and act as an antag-
onist at these sites (Middlemiss, 1984; Sprouse and Aghajanian,
1986). Treatment of rat cultured Leydig cells with propranolol
increased the level of 5-HT with consequent release of corti-
cotropin releasing factor (CRF) and inhibition of steroidogenesis
(Tinajero et al., 1992). The inhibitory effects of propranolol on
male rat sexual behavior, and the impairment of sexual func-
tion in men may be due to its serotonergic action rather than
its antagonistic properties on the adrenergic system (Smith et al.,
1996).
0166-445X/$ – see front matter © 2012 Elsevier B.V. All rights reserved.
doi:10.1016/j.aquatox.2012.03.001